skip to Main Content

New Jersey Medicinal Marijuana Review Panel recommends adding chronic pain and other conditions

TRENTON, NJ— On Thursday, May 11, the New Jersey Medicinal Marijuana Program Review Panel made initial recommendations to the Health Commissioner to approve chronic pain related to musculoskeletal disorders, migraines, anxiety, chronic fatigue related to ailments such as irritable bowel syndrome, Tourrette…

Read More
Back To Top
×Close search